{"disease":{"id":"infertility-embryo-transfer-support","name":"infertility embryo transfer support"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"obe001","indication_name":"Infertility (embryo transfer support)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"OBE001","company_name":"ObsEva SA","drug_phase":"discontinued","molecular_target":"Oxytocin receptor (OXTR)","drug_class":"Oxytocin receptor antagonist; Tocolytic agent","quality_score":null,"revenue":null,"mechanism":"OBE001 is an oxytocin receptor antagonist that inhibits uterine contractions by blocking oxytocin signaling in myometrial smooth muscle."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}